An understanding of the cellular alterations that occur with acute leukemia opens the door to innovative and targeted therapies Published on 03/10/2024 The specialists will give an update on advances in the treatment of myelodysplastic syndromes, myelofibrosis, specific therapies for Acute Myeloid Leukaemia (AML) or Acute Lymphoblastic Leukaemia (ALL).
Artificial Intelligence (AI) opens new horizons in the understanding, diagnosis and treatment of leukaemia Published on 04/10/2023 During the 12th edition of their Open Days, experts from MD Anderson in Houston and other national and international specialists presented some of the latest developments in this field to the participants.